Pharmaceutical

Patient Enrollment Status of the ICEF15 Multi-Regional Phase III Clinical Trial (Fidelia) and Completion of Patient Recruitment in Japan and Europe

Patient Enrollment Status of the ICEF15 Multi-Regional Phase III Clinical Trial (Fidelia) and Completion of Patient Recruitment in Japan and Europe

Innovacell Inc.August 6, 20265
Patient Enrollment Status of the ICEF15 Multi-Regional Phase III Clinical Trial (Fidelia) and Completion of Patient Recruitment in Japan and Europe

About this update from Innovacell Inc.

Innovacell Inc. (504A) Press ReleaseView Attachment

View stock analysis, news, and events for Innovacell Inc.